Immunoreactivity assay for α-particle emitting monoclonal antibody constructs

Anthony S. Bonavia, Michael R. McDevitt, Michael J. Curcio, David A. Scheinberg

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Clinical trials using α-particle radiolabeled antibodies require a rapid and reproducible assay of the immunoreactivity of drugs. While live cell assays are typically used to determine the immunoreactive drug fraction, a fixed cell assay may replace the traditional live cell assay and offer the advantages of rapidity, easy availability and consistency for qualifying drugs for preclinical or clinical studies. We have identified optimal cell fixation and immunoreactivity assay conditions and have validated them by performing the fixed-cell assay in clinical trials.

Original languageEnglish (US)
Pages (from-to)470-474
Number of pages5
JournalApplied Radiation and Isotopes
Volume64
Issue number4
DOIs
StatePublished - Apr 1 2006

Fingerprint

antibodies
cells
drugs
availability

All Science Journal Classification (ASJC) codes

  • Radiation

Cite this

Bonavia, Anthony S. ; McDevitt, Michael R. ; Curcio, Michael J. ; Scheinberg, David A. / Immunoreactivity assay for α-particle emitting monoclonal antibody constructs. In: Applied Radiation and Isotopes. 2006 ; Vol. 64, No. 4. pp. 470-474.
@article{f478d35399a24ae49e78c7391a7bc3b8,
title = "Immunoreactivity assay for α-particle emitting monoclonal antibody constructs",
abstract = "Clinical trials using α-particle radiolabeled antibodies require a rapid and reproducible assay of the immunoreactivity of drugs. While live cell assays are typically used to determine the immunoreactive drug fraction, a fixed cell assay may replace the traditional live cell assay and offer the advantages of rapidity, easy availability and consistency for qualifying drugs for preclinical or clinical studies. We have identified optimal cell fixation and immunoreactivity assay conditions and have validated them by performing the fixed-cell assay in clinical trials.",
author = "Bonavia, {Anthony S.} and McDevitt, {Michael R.} and Curcio, {Michael J.} and Scheinberg, {David A.}",
year = "2006",
month = "4",
day = "1",
doi = "10.1016/j.apradiso.2005.11.004",
language = "English (US)",
volume = "64",
pages = "470--474",
journal = "Applied Radiation and Isotopes",
issn = "0969-8043",
publisher = "Elsevier Limited",
number = "4",

}

Immunoreactivity assay for α-particle emitting monoclonal antibody constructs. / Bonavia, Anthony S.; McDevitt, Michael R.; Curcio, Michael J.; Scheinberg, David A.

In: Applied Radiation and Isotopes, Vol. 64, No. 4, 01.04.2006, p. 470-474.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Immunoreactivity assay for α-particle emitting monoclonal antibody constructs

AU - Bonavia, Anthony S.

AU - McDevitt, Michael R.

AU - Curcio, Michael J.

AU - Scheinberg, David A.

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Clinical trials using α-particle radiolabeled antibodies require a rapid and reproducible assay of the immunoreactivity of drugs. While live cell assays are typically used to determine the immunoreactive drug fraction, a fixed cell assay may replace the traditional live cell assay and offer the advantages of rapidity, easy availability and consistency for qualifying drugs for preclinical or clinical studies. We have identified optimal cell fixation and immunoreactivity assay conditions and have validated them by performing the fixed-cell assay in clinical trials.

AB - Clinical trials using α-particle radiolabeled antibodies require a rapid and reproducible assay of the immunoreactivity of drugs. While live cell assays are typically used to determine the immunoreactive drug fraction, a fixed cell assay may replace the traditional live cell assay and offer the advantages of rapidity, easy availability and consistency for qualifying drugs for preclinical or clinical studies. We have identified optimal cell fixation and immunoreactivity assay conditions and have validated them by performing the fixed-cell assay in clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=32044447222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32044447222&partnerID=8YFLogxK

U2 - 10.1016/j.apradiso.2005.11.004

DO - 10.1016/j.apradiso.2005.11.004

M3 - Article

C2 - 16352433

AN - SCOPUS:32044447222

VL - 64

SP - 470

EP - 474

JO - Applied Radiation and Isotopes

JF - Applied Radiation and Isotopes

SN - 0969-8043

IS - 4

ER -